Prince Charles Hospital
Chermside, Queensland 4032
2 studies enrolling now · 14 studies all time
What they study most
Acute Myocardial Infarction, Cardiovascular Diseases, Cystic Fibrosis, Diabetes Mellitus, Type 2, Diabetic Cardiomyopathies, Graft Rejection, Heart Failure, Heart Failure, Diastolic, Hypertension, Idiopathic Pulmonary Fibrosis, KRAS p, G12c Mutated /Advanced Metastatic NSCLC, Non-Small-Cell Lung Carcinoma
Studies at this site
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure — Recruiting now
- Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200). — Completed
- RESPONDER-HF Trial — Running, not enrolling
- Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI) — Completed
- A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH) — Completed
- Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy — Running, not enrolling
- An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension — Completed
- A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131] — Completed
- Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy — Completed
- A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment — Completed
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early
- Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease — Completed
- Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection — Completed